10 Breast Cancer Clinical Trials in Jonesboro, AR (2026)

Q: How do I join a clinical trial in Jonesboro?

Browse available studies, click one that interests you, and complete the free eligibility form. A study coordinator at the Jonesboro research site will contact you.

Recruiting Breast Cancer Studies in Jonesboro

NCT05879926Recruiting

Evaluating the Addition of Adjuvant Chemotherapy to Ovarian Function Suppression Plus Endocrine Therapy in Premenopausal Patients With pN0-1, ER-Positive/HER2-Negative Breast Cancer and an Oncotype Recurrence Score Less Than or Equal to 25

This Phase III Trial will determine whether adjuvant chemotherapy (ACT) added to ovarian function suppression (OFS) plus endocrine therapy (ET) is superior to OFS plus ET in improving invasive breast ...

Jonesboro, ARPHASE33,960 participantsNRG Oncology

View Study Details

NCT06058377Recruiting

Adding an Immunotherapy Drug, MEDI4736 (Durvalumab), to the Usual Chemotherapy Treatment (Paclitaxel, Cyclophosphamide, and Doxorubicin) for Stage II-III Breast Cancer

This phase III trial compares the addition of an immunotherapy drug (durvalumab) to usual chemotherapy versus usual chemotherapy alone in treating patients with MammaPrint High 2 Risk (MP2) stage II-I...

Jonesboro, ARPHASE33,680 participantsNational Cancer Institute (NCI)

View Study Details

NCT05929768Recruiting

Shorter Chemo-Immunotherapy Without Anthracycline Drugs for Early-Stage Triple Negative Breast Cancer

This phase III trial compares the effects of shorter chemotherapy (chemo)-immunotherapy without anthracyclines to usual chemo-immunotherapy for the treatment of early-stage triple negative breast canc...

Jonesboro, ARPHASE32,400 participantsSWOG Cancer Research Network

View Study Details

NCT06418204Recruiting

Assessing Benefits and Harms of Cannabis/Cannabinoid Use Among Cancer Patients Treated in Community Oncology Clinics

This is a multi-site clinical study enrolling 2000 newly diagnosed patients with breast, colorectal, melanoma, non-Hodgkin lymphoma, or non-small cell lung cancer, who are planning to receive one or m...

Jonesboro, AR2,000 participantsWake Forest University Health Sciences

View Study Details

NCT07391774Recruiting

Testing Whether Hormone Therapy With Ribociclib is as Effective as Chemotherapy Followed by Hormone Therapy With Ribociclib for the Treatment of High Anatomic Stage Breast Cancer With Low Recurrence Risk, The RxFINE-Low Trial

This phase III trial compares standard of care hormone therapy plus ribociclib to chemotherapy followed by hormone therapy plus ribociclib for the treatment of patients with high anatomic stage breast...

Jonesboro, ARPHASE31,978 participantsNational Cancer Institute (NCI)

View Study Details

NCT06876714Recruiting

ShortStop-HER2: 12 Months vs. 6 Months of HER2-targeted Medications for People With HER2+ Breast Cancer Who Had a Pathologic Complete Response After Chemotherapy Plus Trastuzumab

This phase III trial compares 6 months of human epidermal growth factor receptor 2 (HER2)-targeted therapy to 12 months of HER2-targeted therapy for the treatment of HER2-positive (+) breast cancer in...

Jonesboro, ARPHASE31,524 participantsAlliance for Clinical Trials in Oncology

View Study Details

NCT05812807Recruiting

Pembrolizumab vs. Observation in People With Triple-negative Breast Cancer Who Had a Pathologic Complete Response After Chemotherapy Plus Pembrolizumab

The phase III trial compares the effect of pembrolizumab to observation for the treatment of patients with early-stage triple-negative breast cancer who achieved a pathologic complete response after p...

Jonesboro, ARPHASE31,295 participantsAlliance for Clinical Trials in Oncology

View Study Details

NCT03723928Recruiting

S1703 Serum Tumor Marker Directed Disease Monitoring in Patients With Hormone Receptor Positive Her2 Negative Metastatic Breast Cancer

This randomized research trial studies how well serum tumor marker directed disease monitoring works in monitoring patients with hormone receptor positive Her2 negative breast cancer that has spread t...

Jonesboro, ARNA739 participantsSWOG Cancer Research Network

View Study Details

NCT06112613Recruiting

Mobile Health for Adherence in Breast Cancer Patients

This clinical trial compares the use of the connected customized treatment platform (CONCURxP), consisting of using a medication monitoring device called WiseBag along with text message reminders for ...

Jonesboro, ARNA410 participantsECOG-ACRIN Cancer Research Group

View Study Details

NCT06748222Recruiting

E-Mindfulness Approaches for Living After Breast Cancer

NRG-CC015 is a prospective, randomized phase III clinical trial to evaluate the efficacy of two distinct digital approaches for delivering a mindfulness-based intervention: a live, instructor-led vers...

Jonesboro, ARPHASE3402 participantsNRG Oncology

View Study Details

About Breast Cancer Clinical Trials in Jonesboro

Breast cancer is a disease in which cells in the breast grow out of control. It is the most common cancer in women worldwide and can also occur in men. Treatment options include surgery, radiation, chemotherapy, hormone therapy, and targeted therapies.

There are currently 10 breast cancer clinical trials recruiting participants in Jonesboro, AR. These studies are seeking a combined 18,388 participants. Research is being sponsored by NRG Oncology, National Cancer Institute (NCI), SWOG Cancer Research Network and 3 other organizations. Clinical trial participation is free and participants receive study-related medical care at no cost.

Breast Cancer Clinical Trials in Jonesboro — FAQ

Are there breast cancer clinical trials in Jonesboro?

Yes, there are 10 breast cancer clinical trials currently recruiting in Jonesboro, AR. Browse the studies on this page to find one that fits.

How do I join a clinical trial in Jonesboro?

Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Jonesboro research site will contact you about next steps.

Are clinical trials in Jonesboro free?

Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Jonesboro studies also compensate for your time and travel.

What breast cancer treatments are being tested?

The 10 active trials in Jonesboro are testing new therapies including novel drugs, biologics, and treatment approaches for breast cancer.

Data updated July 18, 2026 from ClinicalTrials.gov